This was elucidated through another study on three different human cancer lines (including cervical, breast and hepatoma cell lines) by Zhou et al. [48], in which around 8-fold increase in the caspase 3/7 activity was observed after treatment with andrographolide (50 μM for 6 h), against control [48]. Here, CASP3 is linked to cancer.